Airman Reflects on His Battle with Testicular Cancer
Tech. Sgt. Nathan Combs tells of his fight with stage II non-seminoma, a cancer that affects the testicle but is curable in almost 90% of cases (Source: Disabled World)
Source: Disabled World - November 21, 2016 Category: Disability Tags: Your Disability Stories Source Type: news
DuPont: C8 Lawsuit Should Be Dismissed For Plaintiff's Lack Of Causation
COLUMBUS, Ohio - E.I. du Pont de Nemours and Co. on Oct. 24 filed a brief in Ohio federal court, arguing that one of the cases included in the multidistrict litigation regarding alleged injuries from exposure to perfluorooctanoic acid (known as C8) should be dismissed because the plaintiff cannot establish that C8 from DuPont's Washington Works facility was the proximate and specific cause of his testicular cancer (In re E.I. du Pont de Nemours and Co. C8 Personal Injury Litigation, MDL No. 2433, No. 13-2433, S.D. Ohio). (Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News)
Source: LexisNexis® Mealey's™ Emerging Toxic Torts Legal News - November 1, 2016 Category: Medical Law Source Type: news
Testicular cancer warning: Disease more likely to affect YOUNGER men
TESTICULAR cancer is one of the less common cancers affecting men - and is unusual because it tends to be diagnosed in men aged between 15 and 49. (Source: Daily Express - Health)
Source: Daily Express - Health - October 31, 2016 Category: Consumer Health News Source Type: news
Testicular microlithiasis: Is it linked with testicular cancer?
A Mayo Clinic specialist discusses the relationship between testicular microlithiasis and testicular cancer. (Source: MayoClinic.com - Ask a Specialist)
Source: MayoClinic.com - Ask a Specialist - September 27, 2016 Category: Consumer Health News Source Type: news
Cancer survival: You are most likely to live longest with THESE strains of the disease
MEN who are diagnosed with testicular cancer and women diagnosed with melanoma of the skin are most likely to survive at the end of one and five years, figures reveal. (Source: Daily Express - Health)
Source: Daily Express - Health - September 22, 2016 Category: Consumer Health News Source Type: news
Psychotropic Drugs for Woes of Surviving Testicular Cancer Psychotropic Drugs for Woes of Surviving Testicular Cancer
The cure of testicular cancer is one of the great success stories of cancer research, but young survivors carry the burden of heavy morbidity from cisplatin chemotherapy for the rest of their lives.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 11, 2016 Category: Consumer Health News Tags: Hematology-Oncology Article Source Type: news
Decline in dog sperm quality 'could be a concern for humans'
Conclusion
This animal study aimed to assess changes in sperm quality in dogs over time. Within this, the researchers looked at whether chemicals in the environment may play a role in the observed trends.
The study reported a decline in sperm quality in canines over the 26-year study period, as well as an increase in the incidence of cryptorchidism in the dogs' male offspring during an overlapping timeframe.
The media interest in this study revolves around the idea that the decline in dogs' sperm quality can be linked to the decline in fertility also observed in men.
Further research would need to be conducted in humans ...
Source: NHS News Feed - August 10, 2016 Category: Consumer Health News Tags: Pregnancy/child Lifestyle/exercise Source Type: news
Insurance Status Affected Glioblastoma Survival
Patients with glioblastoma who were uninsured or who had Medicaid at the time of diagnosis were more likely to be diagnosed with a larger tumor and had shorter survival times. (Source: CancerNetwork)
Source: CancerNetwork - August 9, 2016 Category: Cancer & Oncology Authors: Leah Lawrence Tags: Brain Tumors News Practice & Policy Testicular Cancer Source Type: news
Insurance status impacts survival in men with testicular cancer
(Dana-Farber Cancer Institute) Men with testicular cancer who were uninsured or on Medicaid had a higher risk of death from what is normally a curable disease than insured patients, a new study found. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 8, 2016 Category: Global & Universal Source Type: news
DuPont'Acted With Malice,' Says Jury in Cancer Lawsuit DuPont'Acted With Malice,' Says Jury in Cancer Lawsuit
A jury awarded $5.6 million in damages to a man who blames his testicular cancer on drinking water contaminated with DuPont ' s chemicals.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 2, 2016 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Conquering cancer
A 21-year-old student who fought testicular cancer during his degree studies is to graduate with first class honours. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - July 14, 2016 Category: Consumer Health News Source Type: news
DuPont must pay extra $500,000 in lawsuit over Teflon-making chemical
NEW YORK (Reuters) - U.S. jurors ordered DuPont on Friday to pay an additional $500,000 in punitive damages to a man who said he developed testicular cancer from exposure to a toxic chemical used to make Teflon at one of its plants, according to a lawyer for the plaintiff. (Source: Reuters: Health)
Source: Reuters: Health - July 8, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
DuPont Ordered to Pay $5.1 Mln in Trial Over Teflon-Making ChemicalDuPont Ordered to Pay $5.1 Mln in Trial Over Teflon-Making Chemical
A U.S. jury on Wednesday ordered DuPont to pay $5.1 million to a man who said he developed testicular cancer from exposure to a toxic chemical used to make Teflon at one of its plants, according to a DuPont spokesman. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 7, 2016 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
DuPont ordered to pay $5.1 million in trial over Teflon-making chemical
NEW YORK (Reuters) - A U.S. jury on Wednesday ordered DuPont to pay $5.1 million to a man who said he developed testicular cancer from exposure to a toxic chemical used to make Teflon at one of its plants, according to a DuPont spokesman. (Source: Reuters: Health)
Source: Reuters: Health - July 6, 2016 Category: Consumer Health News Tags: healthNews Source Type: news
Many men ignore testicular cancer symptoms for months
HealthDay News Early detection and treatment of testicular cancer is key to beating the disease, a urology specialist says. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 6, 2016 Category: Consumer Health News Source Type: news
